Outsourced Pharma Capacity Update Videos - Small Molecule

  1. PCI Pharma Capacity Update October 2024: Small Molecule 10/23/2024

    Discover how our recent investments have expanded our capacity for developing, manufacturing, and packaging highly potent drug products, leveraging over 35 years of expertise.

  2. Lonza Capacity Update October 2024: Small Molecule 10/23/2024

    See how our AI-enabled Route Scouting Service simplifies the complexity of small molecule APIs, optimizing synthetic routes and accelerating clinical readiness.

  3. Curia Capacity Update October 2024: Small Molecule 10/23/2024

    Use our services and solutions to advance small molecule development — from initial design and optimization to full-scale manufacturing and comprehensive analytical support.

  4. Alcami Capacity Update October 2024: Small Molecule 10/23/2024

    Advance your pharmaceuticals and biologics from development to delivery with our services in oral solid dose development, clinical manufacturing, and commercial packaging solutions.

  5. AbbVie Capacity Update October 2024: Small Molecule 10/23/2024

    Watch this overview of our extensive capabilities, including a deep dive into our HPAPI and API services and the available capacity at our Campoverdi, Italy facility for your next project.

  6. Douglas CDMO Capacity Update July 2024: Small Molecule Finished Dosage Form 8/14/2024

    We specialize in high-potency softgels and liquids and have deep experience producing prescription drugs for classifications including oncology, dermatology, the central nervous system and immunity.

  7. Alcami Capacity Update July 2024: Small Molecule Finished Dosage Form 8/14/2024

    Alcami boasts a state-of-the-art OSD development suite that includes manufacturing equipment, non-GMP analytical testing lab, stability chambers, and small scale blistering equipment.

  8. AustinPx Capacity Update July 2024: Small Molecule Finished Dosage Form 8/14/2024

    Our client-centric approach is designed to simplify the complexity of outsourcing and our team of formulation, analytical and manufacturing experts work with you to overcome challenges.

  9. Curia Capacity Update July 2024: Small Molecule APl And HPAPI Development 8/14/2024

    Learn about Curia’s industry-leading practices in critical disciplines such as high-potency compounds, commercialization of products with our customers, and our growing expertise in chromatography.

  10. AbbVie Capacity Update July 2024: Small Molecule APl And HPAPI Development 8/14/2024

    Review a detailed examination of our HPAPI & API capabilities, with a particular focus on our Campoverdi, Italy facility which currently has capacity available for near-term projects.